Atlas Trials

Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure

Clinical trial NCT01133886 · UNKNOWN

Trial details

NCT number
NCT01133886
Sponsor
King's College London
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
Start date
2010-09-01
Primary completion
2012-09-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.